Cervical Cancer Study

Cervical cancer has become a preventable disease with effective vaccination & screening programs.

Cervical Cancer Study

 About the study findings:

  • India reported 1,23,907 new cases of cervical cancer and 77,348 deaths, according to the study.

 

Countries-wise findings of Cervical Cancer:

  • Though the incidence of cervical cancer has decreased in many parts of the world —notably in Latin America, Asia, Western Europe, and North America — over the past three decades, the burden remains high in many low- and middle-income countries.
  • The study found major declines in cases in Latin American countries including Brazil, Colombia, and Costa Rica; Asian nations like India, Thailand, and South Korea; and Poland, Slovenia, and the Czech Republic in Eastern Europe.
  • Countries with the largest average declines in incidence rates per year include Brazil (8%), Slovenia (7%), Kuwait (7%), and Chile (6%).
  • The highest increases in rates were seen in Latvia (4%), Japan (3%), Ireland (3%), Sweden (3%), Norway (2%), Northern Ireland (2%), Estonia (2%), and China (2%).

 

Database:

  • The study used the International Agency for Research on Cancer’s (IARC) Global Cancer Observatory (GLOBOCAN) 2020 database to estimate the burden of cervical cancer incidence and mortality rates in 185 countries.

 

Incidence:

  • In 2020, overall incidence was 13 per 1,00,000 women; mortality was 7 per 1,00,000 women.
  • As many as 172 out of the 185 countries saw more than the 4 cases per 1,00,000 women per year threshold for elimination set by the World Health Organisation (WHO).
  • The development of effective vaccination against the human papilloma virus (HPV), which causes cervical cancer, and screening programmes have made cervical cancer a largely preventable disease.

 

Target:

  • In 2020, the WHO announced a target to accelerate the elimination of the disease as a public health problem, aiming to reduce incidence to less than 4 cases per 1,00,000 women per year in every country by 2030.

 


Q1) What is Human papillomavirus Infection?

Human papillomavirus (HPV) is a viral infection that is  passed between people through skin-to-skin contact. There are over 100 varieties of HPV, more than 40 of which are passed through sexual contact and can affect your genitals, mouth, or throat.

Source: Indian Express

Latest UPSC Exam 2026 Updates

Last updated on January, 2026

→ Check out the latest UPSC Syllabus 2026 here.

→ Join Vajiram & Ravi’s Interview Guidance Programme for expert help to crack your final UPSC stage.

UPSC Mains Result 2025 is now out.

UPSC Notification 2026 is scheduled to be released on January 14, 2026.

UPSC Calendar 2026 has been released.

UPSC Prelims 2026 will be conducted on 24th May, 2026 & UPSC Mains 2026 will be conducted on 21st August 2026.

→ The UPSC Selection Process is of 3 stages-Prelims, Mains and Interview.

→ Prepare effectively with Vajiram & Ravi’s UPSC Prelims Test Series 2026 featuring full-length mock tests, detailed solutions, and performance analysis.

→ Enroll in Vajiram & Ravi’s UPSC Mains Test Series 2026 for structured answer writing practice, expert evaluation, and exam-oriented feedback.

→ Join Vajiram & Ravi’s Best UPSC Mentorship Program for personalized guidance, strategy planning, and one-to-one support from experienced mentors.

UPSC Result 2024 is released with latest UPSC Marksheet 2024. Check Now!

UPSC Toppers List 2024 is released now. Shakti Dubey is UPSC AIR 1 2024 Topper.

→ Also check Best UPSC Coaching in India

Vajiram Content Team
Vajiram Content Team
UPSC GS Course 2026
UPSC GS Course 2026
₹1,75,000
Enroll Now
GS Foundation Course 2 Yrs
GS Foundation Course 2 Yrs
₹2,45,000
Enroll Now
UPSC Mentorship Program
UPSC Mentorship Program
₹85000
Enroll Now
UPSC Sureshot Mains Test Series
UPSC Sureshot Mains Test Series
₹19000
Enroll Now
Prelims Powerup Test Series
Prelims Powerup Test Series
₹8500
Enroll Now
Enquire Now